Elekta‘s patent outlines automated quality assurance procedures for MR-Linac radiotherapy equipment, focusing on validating the linear accelerator’s operation and analyzing the quality of images produced by the integrated MRI device. The method includes selecting validation procedures, retrieving configuration data, and processing images to ensure operational validity. GlobalData’s report on Elekta gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Elekta, Vaping device aerosol generators was a key innovation area identified from patents. Elekta's grant share as of July 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
Automated quality assurance for mr-linac radiotherapy equipment
The patent US12070623B2 outlines a method for validating the operation of a radiotherapy apparatus that integrates a linear accelerator with an MRI imaging device, referred to as an MR-Linac. The method involves selecting a validation procedure specific to the linear accelerator, retrieving configuration information for the multi-leaf collimator (MLC), and obtaining multiple images from an imaging detector associated with various radiation beams passing through the MLC. These images are processed to assess the operational characteristics of the MR-Linac, determining if it functions within a valid operational range. The method also includes comparing the determined characteristics against allowable thresholds and making necessary adjustments to the MR-Linac if it is found to be operating outside the valid range.
Further details of the method include various validation procedures, such as leaf position validation and alignment checks between the linear accelerator and MRI device. The process involves analyzing a series of images to compute radiation isocenters, detect motion in the beams, and identify leaf and jaw positions. Specific techniques are employed to segment images, compute centers of mass, and generate intensity profiles to ensure accurate validation. The method also accommodates different validation procedures, including flatness and symmetry assessments, by analyzing images taken at various gantry angles. Overall, the patent presents a comprehensive approach to ensuring the precise operation of MR-Linac systems, enhancing the reliability of radiotherapy treatments.
To know more about GlobalData’s detailed insights on Elekta, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
